NeuroSense Therapeutics (NRSN) Q4 2024 Earnings

Dec 18Confirmed
Q1 2024
Q2 2024
Q3 2024
Q4 2024
-0.35
-0.25
-0.15
-0.05

Details

Expected EPS
-0.11
Actual EPS
-0.12
Surprise EPS
-0.01
Surprise Percent
-9.09%

Description

⁨NeuroSense Therapeutics⁩ (⁦NRSN⁩) has reported earnings of ⁦-0.12⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts